Extrovis Private Limited

Global pharma company specializing in APIs, finished dosage forms, and custom pharma services.

2017 | Hyderabad, Telangana (India) | Active
Last Updated:

Extrovis Profile

Key Indicators

  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 1.44 M
  • Company Age 7 Year, 11 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 43.11 Cr
  • Satisfied Charges ₹ 15.00 Cr
  • Revenue Growth 197.41%
  • Profit Growth 156.50%
  • Ebitda 186.41%
  • Net Worth 32.70%
  • Total Assets 259.68%

About Extrovis

Extrovis Private Limited (EPL) is a registered startup operating as a Private Limited Foreign Company Incorporated In India incorporated in India on 07 March 2017 (Seven years and 11 months 24 days old ). Its registered office is in Hyderabad, Telangana, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.44 M.

The company currently has active open charges totaling ₹43.11 Cr. The company has closed loans amounting to ₹15.00 Cr, as per Ministry of Corporate Affairs (MCA) records.

Prasada Gollapudi, Gottumukkula Raju, Hanumantha Kamma, and One other member serve as directors at the Company.

Company Details

  • Location

    Hyderabad, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    extrovis.com

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24304TG2017FTC115706

  • Company No.

    115706

  • Company Classification

    Private Limited Foreign Company Incorporated In India

  • Incorporation Date

    07 Mar 2017

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Pharma

Who are the key members and board of directors at Extrovis?

Financial Performance of Extrovis.

Extrovis Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 197.41% increase. The company also saw a substantial improvement in profitability, with a 156.5% increase in profit. The company's net worth Soared by an impressive increase of 32.7%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
197.41%
Revenue from Operations
199.56%
Total Assets
259.68%
Profit or Loss
156.50%
Net Worth
32.70%
EBITDA
186.41%

What is the Ownership and Shareholding Structure of Extrovis?

In 2023, Extrovis had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹43.11 Cr

Satisfied Charges

₹15.00 Cr

Charges Breakdown by Lending Institutions

  • Others : 32.80 Cr
  • Axis Bank Limited : 10.10 Cr
  • Hdfc Bank Limited : 0.21 Cr

Latest Charge Details

DateLenderAmountStatus
14 Nov 2023Others₹22.50 CrOpen
14 Nov 2023Others₹7.50 CrOpen
04 Apr 2023Hdfc Bank Limited₹1.46 MOpen
04 Jan 2023Others₹8.67 MOpen
04 Jan 2023Others₹1.10 CrOpen

How Many Employees Work at Extrovis?

Extrovis has a workforce of 241 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Extrovis, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Extrovis's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Extrovis

Recent activity within the organization

  • Charges

    A charge registered on 19 Feb 2024 via Charge ID 100888488 with Others was fully satisfied on 02 Apr 2024.

    02 Apr 2024

  • Charges

    A charge with Others amounted to Rs. 15.00 Cr with Charge ID 100888488 was registered on 19 Feb 2024.

    19 Feb 2024

  • Charges

    A charge with Others amounted to Rs. 22.50 Cr with Charge ID 100829100 was registered on 14 Nov 2023.

    14 Nov 2023

  • Charges

    A charge with Others amounted to Rs. 7.50 Cr with Charge ID 100829102 was registered on 14 Nov 2023.

    14 Nov 2023

  • Annual General Meeting

    Extrovis Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.15 Cr with Charge ID 100732836 was registered on 04 Apr 2023.

    04 Apr 2023

Frequently asked questions

  • What is the Incorporation or founding date of Extrovis Private Limited?

    Extrovis Private Limited was incorporated on 07 Mar 2017.

  • What is authorized share capital and paid-up capital of Extrovis Private Limited?

    The authorized share capital of Extrovis Private Limited is ₹ 2.00 Cr and paid-up capital is ₹ 1.44 M.

  • Who are the current board members & directors of Extrovis Private Limited?

    Currently 4 directors are associated with Extrovis Private Limited.

    • Prasada Rao Gollapudi
    • Gottumukkula Angad Ramakrishna Rayappa Raju
    • Hanumantha Rao Kamma
    • Bezawada Venkata Prasad
  • What is the registered address of Extrovis Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Extrovis Private Limited is H No. 5-5-35/102&103 Plot No 22&23 Sy No 379380 & 381 Prashanth Nagar Ie Kukatpally, Balanagar, Hyderabad, Telangana, India, 500072.

  • What is the corporate identification number (CIN) and company number of Extrovis Private Limited?

    The corporate identification number (CIN) of Extrovis Private Limited is U24304TG2017FTC115706 and the company number is 115706 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Extrovis Private Limited?

    The Official website of Extrovis Private Limited is https://www.extrovis.com

  • What has been the recent revenue trend for Extrovis Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Extrovis Private Limited has risen by 197.41%.

  • How many employees does Extrovis Private Limited currently have?

    As Per 2023 financial reports, 241 employees are currently employed by Extrovis Private Limited.

  • What change has been observed in the net worth of Extrovis Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Extrovis Private Limited has experienced an upsurge of 32.70%.

  • What are the total open charges for Extrovis Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Extrovis Private Limited amount to ₹ 43.11 Cr.

  • When was the last Balance Sheet of Extrovis Private Limited filed with the ROC?

    The most recent Balance Sheet for Extrovis Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Pharma Contract R&D